FARMINGDALE, N.Y.--(BUSINESS WIRE)--Misonix, Inc. (NASDAQ: MSON), a developer of minimally invasive ultrasonic medical device technology, which in Europe is used for the ablation of cancer and worldwide for other acute health conditions, today announced the appointment of Mr. Neil Blewitt to be Senior Managing Director of the Company’s Labcaire subsidiary. Labcaire is a 100% owned subsidiary located in Clevedon, United Kingdom and services the endoscope disinfection and ductless fume enclosure equipment markets. Neil comes to Misonix with over 20 years business unit and general manager experience, all in international manufacturing companies. Neil received his BSC with honors in Material Science from the University of Birmingham. Graham Kear, Labcaire’s present Managing Director, will continue to be involved with the new role of Managing Director and CFO. He will report to Mr. Blewitt.
